TrippBio Publishes Data Comparing PanCytoVir™ versus Oseltamivir Against H5N1 and H7N9 Pandemic Influenza
PanCytoVir™ therapy provided 100% protection against lethal H5N1 infection, complete elimination of H5N1 from the lungs, and a greater reduction in inflammation JACKSONVILLE, FL, USA, January 22, 2024 /EINPresswire.com/ -- TrippBio, Inc. ( …